Want to join the conversation?
$AGN said that excluding the FX impact and Namenda IR, all the therapeutic area of businesses delivered double-digit growth. Branded revenues grew double digit for the year. Nine of the top global products grew more than 15% for the year. The launch of LILETTA earlier this year has shown continued growth momentum in unit sales.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?